Detalhe da pesquisa
1.
Diagnosis and management of hepatic encephalopathy: The French recommendations.
Liver Int
; 43(4): 750-762, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36625084
2.
Management of alcohol-related liver disease: the French Association for the Study of the Liver and the French Alcohol Society clinical guidelines.
Liver Int
; 42(6): 1330-1343, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35488390
3.
ABO blood group does not influence Child-Pugh A cirrhosis outcome: An observational study from CIRRAL and ANRS CO12 CIRVIR cohorts.
Liver Int
; 42(6): 1386-1400, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35025128
4.
Targeting cell-intrinsic metabolism for antifibrotic therapy.
J Hepatol
; 74(6): 1442-1454, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33631228
5.
Personalized surveillance for hepatocellular carcinoma in cirrhosis - using machine learning adapted to HCV status.
J Hepatol
; 73(6): 1434-1445, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32615276
6.
Validation of Baveno VI Criteria for Screening and Surveillance of Esophageal Varices in Patients With Compensated Cirrhosis and a Sustained Response to Antiviral Therapy.
Gastroenterology
; 156(4): 997-1009.e5, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30768988
7.
Intrahepatic immune changes after hepatitis c virus eradication by direct-acting antiviral therapy.
Liver Int
; 40(1): 74-82, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31444947
8.
Incidence of Hepatocellular Carcinoma After Direct Antiviral Therapy for HCV in Patients With Cirrhosis Included in Surveillance Programs.
Gastroenterology
; 155(5): 1436-1450.e6, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30031138
9.
Compliance With Hepatocellular Carcinoma Surveillance Guidelines Associated With Increased Lead-Time Adjusted Survival of Patients With Compensated Viral Cirrhosis: A Multi-Center Cohort Study.
Gastroenterology
; 155(2): 431-442.e10, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29729258
10.
Non-virological factors are drivers of hepatocellular carcinoma in virosuppressed hepatitis B cirrhosis: Results of ANRS CO12 CirVir cohort.
J Viral Hepat
; 26(3): 384-396, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30380181
11.
Extrahepatic cancers are the leading cause of death in patients achieving hepatitis B virus control or hepatitis C virus eradication.
Hepatology
; 68(4): 1245-1259, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-29663511
12.
Liver Resection for Solitary Transplantable Hepatocellular Carcinoma: The Role of AFP-Score.
World J Surg
; 43(1): 221-229, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30128773
13.
Positron emission tomography/computed tomography with 18F-fluorocholine improve tumor staging and treatment allocation in patients with hepatocellular carcinoma.
J Hepatol
; 69(2): 336-344, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29518452
14.
Eradication of Hepatitis C Virus Infection in Patients With Cirrhosis Reduces Risk of Liver and Non-Liver Complications.
Gastroenterology
; 152(1): 142-156.e2, 2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27641509
15.
Prognostic value of viral eradication for major adverse cardiovascular events in hepatitis C cirrhotic patients.
Am Heart J
; 198: 4-17, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29653647
16.
Bacterial infection in compensated viral cirrhosis impairs 5-year survival (ANRS CO12 CirVir prospective cohort).
Gut
; 66(2): 330-341, 2017 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-26511797
17.
Sofosbuvir-Daclatasvir-Simeprevir Plus Ribavirin in Direct-Acting Antiviral-Experienced Patients With Hepatitis C.
Clin Infect Dis
; 64(11): 1615-1618, 2017 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28369411
18.
EASL Recognition Award Recipient 2022: Dr. Sophie Lotersztajn.
J Hepatol
; 77(2): 282-283, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35750546
19.
Liver transplantation versus liver resection for hepatocellular carcinoma in intention to treat: An attempt to perform an ideal meta-analysis.
Liver Transpl
; 23(6): 836-844, 2017 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28295992
20.
Retreatment with sofosbuvir and simeprevir of patients with hepatitis C virus genotype 1 or 4 who previously failed a daclatasvir-containing regimen.
Hepatology
; 63(6): 1809-16, 2016 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-26853230